Diverticulitis

How it works

Risks & contraindications

Evidence quality

Other

Highlighted claims

• Diverticular disease involves herniation of colonic mucosa and submucosa through the muscular wall. — Pilot multicentre open-label randomised controlled trial assessing prevention of recurrent DIverticulitis through the use of pelvic floor PHYSIOtherapy: DIPHYSIO study protocol
• Diverticulitis occurs when diverticula become inflamed and classically presents with left lower quadrant pain, altered bowel motions, and fever. — Pilot multicentre open-label randomised controlled trial assessing prevention of recurrent DIverticulitis through the use of pelvic floor PHYSIOtherapy: DIPHYSIO study protocol
• An estimated 5–25% of people with diverticulosis develop diverticulitis at least once. — Pilot multicentre open-label randomised controlled trial assessing prevention of recurrent DIverticulitis through the use of pelvic floor PHYSIOtherapy: DIPHYSIO study protocol
• Approximately 20–55% of people who develop diverticulitis experience recurrent episodes. — Pilot multicentre open-label randomised controlled trial assessing prevention of recurrent DIverticulitis through the use of pelvic floor PHYSIOtherapy: DIPHYSIO study protocol
• Recurrent diverticulitis can lead to repeat hospitalisation, invasive intervention, chronic pain, reduced productivity, and lower quality of life. — Pilot multicentre open-label randomised controlled trial assessing prevention of recurrent DIverticulitis through the use of pelvic floor PHYSIOtherapy: DIPHYSIO study protocol
• The pathogenesis of diverticular disease is multifactorial and not fully understood. — Pilot multicentre open-label randomised controlled trial assessing prevention of recurrent DIverticulitis through the use of pelvic floor PHYSIOtherapy: DIPHYSIO study protocol